Compass Therapeutics, Inc.
CMPX • NASDAQ
Compass Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas J. Schuetz, with a market cap of $981.5M.
Market Cap$981.5M
Employees32.0
CEOThomas J. Schuetz
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Compass Therapeutics, Inc. FAQ
Common questions about Compass Therapeutics, Inc.
Compass Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of -$600.0K.
Compass Therapeutics, Inc. has approximately 32 employees.